Martina Lenzuni

Dr. Martina Lenzuni

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Marco ContardiMarco Contardi
Marco Contardi
MLMartina Lenzuni
Martina Lenzuni
FFFabrizio Fiorentini
Fabrizio Fiorentini
MSMaria Summa
Maria Summa
Rosalia BertorelliRosalia Bertorelli
Rosalia Bertorelli
AAAthanassia Athanassiou
Athanassia Athanassiou
Alterations of skin homeostasis are widely diffused in our everyday life both due to accidental injuries, such as wounds and burns, and physiological conditions, such as late-stage diabetes, dermatitis, or psoriasis. These events are locally characterized by an intense inflammatory response, a high generation of harmful free radicals, or an impairment in the immune response regulation, which can profoundly change the skin tissue’ repair process, vulnerability, and functionality. Moreover, diabetes diffusion, antibiotic resistance, and abuse of aggressive soaps and disinfectants following the COVID-19 emergency could be causes for the future spreading of skin disorders. In the last years, hydroxycinnamic acids and derivatives have been investigated and applied in several research fields for their anti-oxidant, anti-inflammatory, and anti-bacterial activities. First, in this study, we give an overview of these natural molecules’ current source and applications. Afterwards, we review their potential role as valid alternatives to the current therapies, supporting the management and rebalancing of skin disorders and diseases at different levels. Also, we will introduce the recent advances in the design of biomaterials loaded with these phenolic compounds, specifically suitable for skin disorders treatments. Lastly, we will suggest future perspectives for introducing hydroxycinnamic acids and derivatives in treating skin disorders.

12 July 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
MLMartina Lenzuni
Martina Lenzuni
GSGiulia Suarato
Giulia Suarato
DMDalila Miele
Dalila Miele
RCRiccardo Carzino
Riccardo Carzino
MRMarco Ruggeri
Marco Ruggeri
AAAthanassia Athanassiou
Athanassia Athanassiou
Drug-eluting stents (DES) have been widely used for the treatment of cardiovascular diseases. Nevertheless, chronic inflammation and delayed re-endothelialization still represent challenges for their clinical use. In the present work, we developed novel bilayer coatings for stent applications that could overcome these limitations, exclusively using biodegradable plant-based drugs and polymers. In particular, stainless steel surfaces were coated with rutin-loaded zein (the active layer) and cross-linked alginate (the sacrificial layer) via facile dip and spray coating methods. Various mechanical tests and analysis tools, such as infrared spectroscopy, water contact angle measurements, and scanning electron microscopy were used to characterize the coated surfaces. Degradation and release studies of the films were extensively carried out and compared. The release rate of rutin from the bilayer coating reached 66.1 ± 3.2% within 24 hours of incubation (initial burst period), while the rest of the drug was released over 21 days in a sustained manner. Antioxidant assays confirmed that rutin retained its free radical scavenging ability after being eluted in phosphate buffer at 37 °C. In vitro results with human fibroblasts and endothelial cells suggested that the coating materials and their degradation products are highly biocompatible. In conclusion, our novel drug-eluting coatings, fabricated with natural biodegradable polymers, are promising materials for DES applications, allowing a sustained drug delivery and improving the biocompatibility of cardiovascular implanted devices.

11 April 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
AMAnnalisa Martorana
Annalisa Martorana
MLMartina Lenzuni
Martina Lenzuni
MCMarco Contardi
Marco Contardi
FPFabio Salvatore Palumbo
Fabio Salvatore Palumbo
Salvatore CataldoSalvatore Cataldo
Salvatore Cataldo
GPGiovanna Pitarresi
Giovanna Pitarresi

23 January 2023 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
MLMartina Lenzuni
Martina Lenzuni
SBSilvio Bonfadini
Silvio Bonfadini
LCLuigino Criante
Luigino Criante
FZFilippo Zorzi
Filippo Zorzi
MSMaria Summa
Maria Summa
AAAthanassia Athanassiou
Athanassia Athanassiou
Biodegradable stent coatings have shown great potential in terms of delivering drugs to a damaged vessel wall, and their release profiles are key elements governing the overall performance of drug-eluting stents (DESs). However, release and degradation kinetics are usually not tested under simulated physiological conditions or in dynamic environments, both essential aspects in the design of novel DESs. To bridge this gap, fused silica-based microfluidic systems, with either round or square channel cross-sections, were designed to mimic the microenvironment of a stented vessel. In particular, we fabricated and characterized microfluidic chips based on customizable channels, which were spray-coated with a naturally-derived, rutin-loaded zein solution, to perform a comprehensive study under flow conditions. Dynamic assays after 6 hours showed how the degradation of the zein matrix was affected by the cross-sectional conformation (∼69% vs. ∼61%, square and round channel, respectively) and the simulated blood fluid components (∼55%, round channel with a more viscous solution). The released amount of rutin was ∼81% vs. ∼77% and ∼78% vs. ∼74% from the square and round channels, using the less and more viscous blood-simulated fluids, respectively. Fitting the drug release data to Korsmeyer–Peppas and first-order mathematical models provided further insight into the mechanism of rutin release and coating behavior under flowing conditions. More importantly, whole blood tests with our newly developed microfluidic platforms confirmed the hemocompatibility of our zein-based coating. In detail, in-flow and static studies on the blood cell behavior showed a significant reduction of platelet adhesion (∼73%) and activation (∼93%) compared to the stainless-steel substrate, confirming the benefits of using such naturally-derived coatings to avoid clogging. Overall, our microfluidic designs can provide a key practical tool for assessing polymer degradation and drug release from degradable matrices under flowing conditions, thus aiding future studies on the development of hemocompatible, controlled-release coatings for DESs.

29 July 2025 in Journal of Materials Research and Technology
Verified
Journal Article
Open access
MMMarco Migliorati
Marco Migliorati
SDSara Drago
Sara Drago
MLMartina Lenzuni
Martina Lenzuni
AMAlessandra Marrella
Alessandra Marrella
Paolo GiannoniPaolo Giannoni
Paolo Giannoni
ALAlberto Lagazzo
Alberto Lagazzo

6 May 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
MRMarco Ruggeri
Marco Ruggeri
MLMartina Lenzuni
Martina Lenzuni
Giulia SuaratoGiulia Suarato
Giulia Suarato
BVBarbara Vigani
Barbara Vigani
CINZIA BOSELLICINZIA BOSELLI
CINZIA BOSELLI
Giuseppina SandriGiuseppina Sandri
Giuseppina Sandri
Periodontal regeneration is extremely limited and unpredictable due to structural complications, as it requires the simultaneous restoration of different tissues, including cementum, gingiva, bone, and periodontal ligament. In this work, spray-dried microparticles based on green materials (polysaccharides - gums - and a protein - silk fibroin) are proposed to be implanted in the periodontal pocket as 3D scaffolds during non-surgical treatments, to prevent the progression of periodontal disease and to promote the healing in mild periodontitis. Arabic or xanthan gum have been associated to silk fibroin, extracted from Bombyx mori cocoons, and loaded with lysozyme due to its antibacterial properties. The microparticles were prepared by spray-drying and cross-linked by water vapor annealing, inducing the amorphous to semi-crystalline transition of the protein component. The microparticles were characterized in terms of their chemico-physical features (SEM, size distribution, structural characterization - FTIR and SAXS, hydration and degradation properties) and preclinical properties (lysozyme release, antibacterial properties, mucoadhesion, in vitro cells adhesion and proliferation and in vivo safety on a murine incisional wound model). The encouraging preclinical results highlighted that these three-dimensional (3D) microparticles could provide a biocompatible platform able to prevent periodontitis progression and to promote the healing of soft tissues in mild periodontitis.